  BPRS (Brief Psychiatric Rating Scale)Persons having or suspected of having schizophrenia or other psychotic disorder manifest the disorder in multiple ways. The BPRS assesses the level of 18 symptom constructs such as hostility, suspiciousness, hallucination, and grandiosity. It is particularly useful in gauging the efficacy of treatment in patients who have moderate to severe psychoses.It is based on the clinician's interview with the patient and observations of the patient's behavior over the previous 2-3 days. The patient's family can also provide the behavior report. The rater enters a number for each symptom construct that ranges from 1 (not present) to 7 (extremely severe). The time necessary to complete the interview and scoring can be as little as 20-30 minutes.
More About Schizophrenia and the BPRS
October 22, 2009 Risperdal Tablet, Orally Disintegrating More » October 22, 2009 Risperdal Tablet More » August 24, 2009 The FDA recently approved iloperidone (Fanapt, Vanda Pharmaceuticals) for the treatment of schizophrenia, reversing a July 2008 determination that the New Drug Application (NDA) was “not approvable.” An FDA spokesperson explained in an interview in... More » June 2, 2009 New treatments for patients with schizophrenia may be on the horizon, according to research presented at the annual meeting of the American Psychiatric Association in San Francisco. While some of these therapies may help treat the negative and... More » March 6, 2009 The FDA Pediatric Advisory Committee met in November to review drug trials and safety data for several medications under consideration for pediatric-specific labeling. Drugs included the antipsychotics olanzapine (Zyprexa) and risperidone... More »
|
 A large number of psychiatric tests, scales, and forms have been created over the years to help in diagnosing mental illness and assisting in treatment and follow-up. This Web-based service offers copies of some of the most popular and useful instruments. The hope is that healthcare professionals—whether in specialty practices, primary-care settings, or emergency services—will find this format convenient and useful, allowing them to find the right instrument quickly, print it out for immediate use with patients, and add the findings to their records. Since most of the tools are designed for repeated use over time, they will provide not only a longitudinal view but also document the medical record. In addition to the forms themselves, you will find instructions on how to administer and score the scales as well as related articles and links to other useful guidance. When appropriate, we will supply video resources for additional insights. These scales have demonstrated high levels of accuracy and validity and the results can give important clues to possible mental disorders that warrant follow up. However, please remember that they depend on the skills of the clinicians administering them and the accuracy of the information provided by the patients. |
|||||||||
© 1996 - 2009 CMPMedica LLC, a
United Business Media company
Privacy Statement -
Terms of Service -
Advertising Information
